Last Trading Day for Shares with Pre-Emptive Rights
Aquaporin A/S, the renowned water technology innovator, is announcing an important milestone regarding its rights issue—today marks the last day for trading shares that carry pre-emptive rights.
Investors need to understand the implications of these rights. If shares are traded after the market closes at 5:00 p.m. CET today, they will not include rights allowing for subscription to new shares in the company’s upcoming rights issue.
Understanding the Rights Issue
For shareholders, registered as of a specified cutoff time, the company is offering ten pre-emptive rights for each share owned. These rights are essential for existing shareholders wishing to buy additional shares at a predetermined price.
Key Dates
The subscription terms of the rights issue specify that the subscription ratio is set at 10:3, which means three rights are necessary to secure one new share. The total price for each new share is pegged at DKK 1.
Rights Trading Period
The trading of pre-emptive rights will commence tomorrow at 9:00 a.m. CET, concluding on January 16. It’s crucial for investors to take prompt action, as any rights not utilized before the deadline will lapse, resulting in no value.
Subscription Period Explained
Furthermore, the actual subscription window for the new shares is set to open on January 7 and will remain available until January 20 at 5:00 p.m. CET. This subscription period is vital for ensuring shareholders do not miss out on the chance to expand their holdings in Aquaporin.
Potential for Dilution
It’s important to note that shareholders who choose not to exercise their rights to subscribe fully risk dilution of up to 77%. This significant figure highlights the importance of acting within the rights and subscription periods.
Aquaporin’s Mission and Innovations
Aquaporin stands at the forefront of revolutionizing water filtration technology. The company, with its headquarters in Denmark, operates globally, embracing modern biotechnology to tackle pressing water challenges worldwide.
By leveraging a unique combination of biology, chemistry, and physics, Aquaporin has developed the fascinating Aquaporin Inside® technology. It’s worth noting that this technology is not only inspired by nature but also based on Nobel Prize-winning research.
Applications of Aquaporin’s Technology
The versatility of Aquaporin’s inventions allows them to tackle diverse water treatment needs, from industrial wastewater purification to enhancing drinking water quality. Notably, their technology has even found its way into NASA's projects in space.
Engagement with Stakeholders
The company aims to engage with various stakeholders and partners to ensure they contribute effectively to resolving water treatment issues responsibly. Aquaporin's commitment fosters collaborative efforts, ensuring innovative solutions that align with global needs.
Contact Information
For further insights or inquiries, investors are encouraged to contact Ulrik Lund Jakobsen, Chief Executive Officer, or Klaus Juhl Wulff, Chief Financial Officer. Your feedback and questions are welcome as we navigate these significant changes together.
Frequently Asked Questions
What is the significance of today’s trading deadline?
Today is the last opportunity for shareholders to trade shares with pre-emptive rights, essential for participating in the rights issue.
How does the subscription ratio work?
The ratio of 10:3 means that for every ten rights, shareholders can subscribe for three new shares at a set price.
What happens if I don’t use my pre-emptive rights?
Any rights not exercised before the expiration will simply lapse and hold no value.
When does the subscription period start?
The subscription period will begin on January 7 and conclude on January 20.
What risk do I face regarding dilution?
Shareholders failing to fully subscribe may experience significant dilution—up to 77%—in their holdings, emphasizing the importance of participation in the rights issue.
